facts about glutathione and parkinson's disease Frontiers Nrf2–Keap1 Pathway and NLRP3 Inflammasome

These findings do not constitute proof of efficacy in humans

Another group of researchers, in Taiwan, has also conducted several studies of BPC-157

This dual agonist research peptide blend is typically discussed in relation to receptor binding, signal transduction, and downstream pathway activation within neuroendocrine and metabolic research models

References : [1] [3] [4] [5] [6] National Library of Medicine, Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data, Pickart, L., Margolina, A., July 2018 [2] National LIbrary of Medicine, The potential of GHK as an anti-aging peptide, Dou, Y., Lee, A., Zhu, L., Morton, J., Ladiges, W., March 2020

Even with psychological training, when it comes to my lived experience, I struggle to tease out what is what